Page last updated: 2024-11-01

ondansetron and Exanthema

ondansetron has been researched along with Exanthema in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rosenberg, M1
Tram, C1
Kuper, A1
Daneman, N1

Other Studies

1 other study available for ondansetron and Exanthema

ArticleYear
Rash associated with pandemic (H1N1) influenza.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Feb-23, Volume: 182, Issue:3

    Topics: Adult; Antipruritics; Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Exanthema; Hum

2010